Showing results out of
Blog post by Eleni Tzampatzopoulou, EMBL-EBI Impact Manager In summer 2024, EMBL-EBI ran a user survey, inviting our community to let us know how they use the open data resources we jointly manage with our collaborators. With over 2,300 responses from 126 countries, we were delighted by the depth…
2024
announcements
In the era of data-driven biology, integrating information from different resources is essential yet often challenging. The BioChemGraph project addresses this challenge by creating infrastructure that consolidates structural, functional, and biochemical annotations for small molecules and their…
2024
updates-from-data-resources
Ensembl 113 brings major gene and regulatory feature annotation updates in Homo sapiens (human) and Mus musculus (mouse).
2024
updates-from-data-resources
Creators of AI system AlphaFold receive 2024 Nobel Prize for Chemistry.
SCIENCE & TECHNOLOGY2024
sciencescience-technology
EMBL-EBI’s microbiome data resource MGnify produces a valuable trove of protein sequence data through its ongoing analysis of microbiome derived data. Two new MGnify Proteins web resources make this dataset easily accessible and searchable, both for large queries across the entire database…
2024
updates-from-data-resources
EMBL-EBI's new Head of Research shares his plans and priorities.
PEOPLE & PERSPECTIVES2024
people-perspectivesperspectives
Where to start when thinking about the sustainability of informatics projects
2023
perspectives
Large language models are changing the way we carry out scientific data curation, annotation, and research, setting the stage for a more efficient understanding of scientific literature
EMBLetc2023
Users no longer need to download large datasets with the new galleries feature
2023
updates-from-data-resources
The latest Expression Atlas release is now live and contains a wider range of RNA-seq and proteomics datasets.
2023
updates-from-data-resources
Construction begins on EMBL-EBI's new building named after Janet Thornton.
EMBL ANNOUNCEMENTSLAB MATTERS2023
announcementsembl-announcementslab-matters
A third of all known proteins are either completely or partially unstructured. EMBL scientists contributed to a new set of guidelines – Minimum Information About a Disorder Experiment (MIADE) – that will help researchers share data on unstructured proteins in a more useful way and will enable…
SCIENCE & TECHNOLOGY2023
sciencescience-technology
New framework to improve the FAIRness of clinical and molecular datasets
2023
perspectives
HoloFood, the first consistent collection of multiomic data about chicken and salmon gut microbiomes, set to enable the development of better animal feeds.
SCIENCE & TECHNOLOGY2023
sciencescience-technologytechnology-and-innovation
Postdoctoral researcher Carolin Sauer is leveraging long-read sequencing to develop new detection methods for various cancers.
LAB MATTERSPEOPLE & PERSPECTIVES2023
lab-matterspeople-perspectivesresearch-highlights
Understanding chromothripsis offers insights into how cancer develops.
SCIENCE & TECHNOLOGY2023
research-highlightsscience-technology
Why open data from model organisms is essential for rare disease research.
2023
perspectivesscience
The Open Global Data Citation Corpus will become a central place for research data citations, and include accession numbers supplied by Europe PMC.
2023
announcements
Jo McEntyre talks about data services, open data and a new era for research assessment.
LAB MATTERSPEOPLE & PERSPECTIVES2023
lab-matterspeople-perspectivesperspectives
EMBL is one of the partners of this project that aims to accelerate drug discovery and development, bringing in expertise from EMBL Grenoble and EMBL-EBI.
LAB MATTERSSCIENCE & TECHNOLOGY2023
lab-mattersscience-technology
Open data played a pivotal role in the development of the AlphaFold AI. The same open principles now apply to AlphaFold predictions.
2023
perspectivesscience
New agreement with UN organisation will enable cooperation in the fields of open science, capacity building, and talent development
CONNECTIONSLAB MATTERS2023
connectionslab-matters
Open Targets is using artificial intelligence and machine learning to identify and prioritise drug targets.
SCIENCE & TECHNOLOGY2023
sciencescience-technologytechnology-and-innovation
Open data resources that enable global research and development recognised by the Global Biodata Coalition.
2022
announcementsscience
Unveiling a useful tool for understanding human lung development.
2022
research-highlightsscience
Our experts discuss the importance of open science for food security and preserving global biodiversity.
2022
perspectivesscience
Data continues to be available in BioStudies.
2022
updates-from-data-resources
Cell biologist Anthony Hyman and DeepMind’s Demis Hassabis and John Jumper were announced among 25 Breakthrough Prize recipients
EMBL ANNOUNCEMENTSLAB MATTERS2022
embl-announcementslab-matters
Ewan Birney, Deputy Director General of EMBL and Director of EMBL-EBI, reveals the key factors that enabled AlphaFold to change the world of biology.
PEOPLE & PERSPECTIVES2022
people-perspectivesperspectivesscience
AlphaFold database offers a look at 3D protein universe.
SCIENCE & TECHNOLOGY2022
sciencescience-technologytechnology-and-innovation
The Ensembl 107 release contains updates to regulatory annotations and updated vertebrate and metazoan species.
2022
updates-from-data-resources
Funding set to support data resources for key areas of antimicrobial resistance, sustainable agriculture and biodiversity loss
2022
announcements
Fergal Martin discusses the importance of open access data and his work in different biodiversity initiatives
LAB MATTERSPEOPLE & PERSPECTIVES2022
lab-matterspeople-perspectives
Janet Thornton, the inaugural winner of the FEBS Journal Open Science Award, explains the importance and impact of open science.
LAB MATTERSPEOPLE & PERSPECTIVES2022
lab-matterspeople-perspectivesperspectives
How text mining collaborations benefit our research, data resources, and the wider scientific community.
SCIENCE & TECHNOLOGY2022
sciencescience-technologytechnology-and-innovation
Peter Harrison discusses the importance of data accessibility and his passion for biodiversity and agricultural genomics.
LAB MATTERSPEOPLE & PERSPECTIVES2022
lab-matterspeople-perspectives
Virginie Uhlmann shares her tips for using deep learning for bioimage analysis in the life sciences.
SCIENCE & TECHNOLOGY2022
perspectivessciencescience-technology
EMBO Director Fiona Watt discusses preprints, data sharing, and evaluation in light of EMBL’s new Open Science policy
LAB MATTERSPEOPLE & PERSPECTIVES2022
lab-matterspeople-perspectives
The GBC is a coalition of life sciences and biomedical research funders that aims to optimise the funding and management of biodata resources worldwide. The organisation has two priority aims: to better coordinate and share approaches for efficient management and growth of the biodata…
2022
announcements
Researchers from the MANE collaboration bring you the most comprehensive human genome annotation dataset to date.
SCIENCE & TECHNOLOGY2022
research-highlightssciencescience-technology
Zamin Iqbal and his team are working with researchers all over the globe to help put a stop to Tuberculosis
SCIENCE & TECHNOLOGY2022
perspectivessciencescience-technology
Our researchers highlight their contributions to the Darwin Tree of Life project and how new genome annotations helps to further biodiversity research
SCIENCE & TECHNOLOGY2022
announcementssciencescience-technology
The African BioGenome Project aims to safeguard biodiversity and build bioinformatics capacity across Africa
SCIENCE & TECHNOLOGY2022
perspectivessciencescience-technology
Deep learning models can improve protein annotations and has helped expand the Pfam database.
SCIENCE & TECHNOLOGY2022
perspectivessciencescience-technology
Open Targets, a consortium focused on drug target identification, prioritisation, and validation, announced today that Pfizer has joined as a partner.
CONNECTIONS2022
announcementsconnectionsscience
An exploration of where in the world genomics methods are applied and where the data are used.
SCIENCE & TECHNOLOGY2022
perspectivessciencescience-technology
On track to reach an ambitious goal of 3,000 genomes sequenced by the end of 2022, what’s next for the Earth Biogenome Project?
SCIENCE & TECHNOLOGY2022
announcementssciencescience-technology
Melissa Harrison joins EMBL-EBI as the new Team Leader of Literature Services. We found out more about her plans for open access publishing and Europe PMC.
LAB MATTERSPEOPLE & PERSPECTIVES2022
lab-matterspeople-perspectives
A look back at some of the 2021 highlights from the Darwin Tree of Life partner institutes.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
EMBL announces the release of its new Open Science Policy, contributing to positive culture change across the life sciences.
LAB MATTERS2021
lab-matters
Independent study reveals that EMBL-EBI open data resources are critical for the life sciences.
LAB MATTERSSCIENCE & TECHNOLOGY2021
lab-mattersscience-technology
The BY-COVID project aims to make infectious disease data, including COVID-19, openly available to everyone.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Profiling M. tuberculosis strains from 27 countries to reveal causes of drug resistance.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Ian Dunham walks us through his career so far including working on the human genome project, seeing his work on the cover of Nature and his current role as Director of Open Targets.
LAB MATTERSPEOPLE & PERSPECTIVES2021
lab-matterspeople-perspectives
3D-Beacons Network acts as a one-stop shop for protein structures by combining and standardising data from several providers.
CONNECTIONS2021
connectionsscience
Partners use AlphaFold, the AI system recognised last year as a solution to the protein structure prediction problem, to release more than 350,000 protein structure predictions including the entire human proteome to the scientific community.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
DeepMind and EMBL-EBI to make millions of protein structure predictions freely available to the scientific community.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
A discussion of the applications that AlphaFold DB may enable and the possible impact of the resource on science and society.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Researchers establish a framework for identifying new drugs capable of exploiting a cell’s own machinery.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Scientists from the CABANA project explore how open data is benefiting global research efforts.
CONNECTIONS2021
connectionsscience
Researchers have used human medical and genetic data from UK Biobank to investigate the genetics of age-related diseases
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Open letter galvanises life science community in support of open COVID-19 data
EMBL ANNOUNCEMENTSLAB MATTERS2021
embl-announcementslab-matters
Open access data benefits millions of scientists around the world and is essential for a rapid response to the COVID-19 pandemic.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
The new collaborative space will help scientists, public health and healthcare professionals around the world to fight the coronavirus pandemic.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
EMBL-EBI set to launch European COVID-19 Data Platform to help store, share, and analyse research data linked to the COVID-19 pandemic.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
The BioImage Archive - EMBL-EBI's first dedicated imaging data resource
SCIENCE & TECHNOLOGY2019
sciencescience-technology
Pharmaceutical company Sanofi strengthens drug targets discovery collaboration Open Targets
CONNECTIONSLAB MATTERS2018
connectionslab-matters
Ioanna Ydraiou and Bernd Pulverer spoke about their view of challenges and opportunities of OA.
LAB MATTERS2018
lab-matters
New BioModels infrastructure supports significantly more model formats and offers improved search
SCIENCE & TECHNOLOGY2017
sciencescience-technology
Q&A with EMBL-EBI's Head of Chemical Biology data services
PEOPLE & PERSPECTIVES2017
people-perspectivesscience
Introducing one of the largest collections of high-quality human induced pluripotent stem cells
SCIENCE & TECHNOLOGY2017
sciencescience-technology
New method combines signalling pathway data resources to improve systems biology research
SCIENCE & TECHNOLOGY2016
sciencescience-technology
BLUEPRINT: EMBL-EBI and the push to decipher the blood epigenome
SCIENCE & TECHNOLOGY2016
sciencescience-technology
Independent analysis of EMBL-EBI underscores the value and impact of open data in the life sciences
LAB MATTERS2016
lab-matters
Pioneering target validation collaboration expands to accelerate drug discovery research.
CONNECTIONSLAB MATTERS2016
connectionslab-matters
No results found